multistep lymphoproliferative process leading several decades later to the development of leukemic disease. Thus, infection of thymocytes early in life might be directly correlated with the development of ATL. In the present study, we show that in vitro infection of mature {CD2+CD3') or immature (CD2+CD3-) thymocytes resulted in the exogenous interleukin (lL)-2-dependent proliferation of HTLV-l-positive thymocytes, most of them displaying a CD2+CD3-CD4+ phenotype and expressing the CD25 molecule, the a chain of the
IL-2 receptor. Furthermore, the CD80 and CD54 antigens, normally expressed by thymic stromal cells, were detected on these transformed thymocytes, indicating that HTLV-I infection may disturb the cooperation between thymocytes and their thymic environment. These HTLV-l-positive thymocytes were producing significant amounts of IL-6, which was found to be implicated in their proliferation and in the expression of CD25, as demonstrated by blocking experiments using a monoclonal antibody to 11-6. The present study suggests that immature thymocytes may provide an environment favorable to the unfolding of events leading to leukemia. 0 1995 by The American Society of Hematology.
A remarkable feature shown by studies on virus transmission concerns the link between the age of HTLV-I infection and the development of ATL. Indeed, this disease appears to develop mainly in individuals infected from their mothers, mostly through breastfeeding, indicating that the incubation period of the disease is spanning several years? These observations underline that cellular and molecular events triggered by HTLV-I infection are of major importance in initiating the lymphoproliferative process leading through several stages to the establishment of leukemia. As proviral expression was found to be silent or very low in ATL cells, HTLV-I should intervene in triggering the polyclonal proliferation of activated T-cells, thus favoring the subsequent genetic events leading to the clonal or oligoclonal expansion of leukemic cells.
Collectively, these observations suggested that infection of specific target cells early in life may be directly correlated with the development of ATL several decades later and led us to investigate how the stage of differentiation of cells infected with HTLV-I is contributing to the evolution of the leukemogenic process. Indeed, mature hematopoietic cells are derived through committed cells from a hierarchy of stem cells that differ in their ability to self-renew and to differentiate. The differentiation pathway involves a series of genetic changes correlating with the expression of cellular antigens (growth factors receptors and adhesion molecules) that have been instrumental in the definition of distinct successive subsets along a specific hematopoietic lineage. As indicated by studies of the mechanisms of animal retrovirusinduced leukemia, immature cells may be more prone to undergo specific genetic changes leading to the leukemic phenotype. Consequently, target cells of the leukemogenic activity of HTLV-I might be recruited among T-cell precursors, inasmuch as HTLV-I provirus has not been detected in pluripotent progenitor cells located in the bone marrow of ATL patients7
The main site of T-cell development is the thymus in which early precursors of T lymphocytes proliferate and mature, expressing in an ordered pathway, a set of membrane molecules that define important steps in the process of thymic differentiation.*"" Thus, the CD2 accessory molecule is one of the earliest cell surface markers to appear on T-cell precursors. These immature CDZ'TCWCDT thymocytes acquire the CD4 and CD8 antigens and reardnge their T-Blood, Vol 86, NO 4 (August 15), 1995: pp 1444-1452
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From cell receptor (TCR) genes. Among these cortical thymocytes, cells expressing CD3 and TCR proteins emerge, which interact with thymic stromal major histocompatibility complex (MHC) molecule^.^.^ The T-cell specificity repertoire is thus determined through two consecutive processes of positive (self-restriction) and negative (self-tolerance) selection, which are thought to occur in cortical thymocytes or in the corticomedullary transitional cells. The surviving thymocytes increase expression of CD3/TCR, but lose either CD4 or CD8 to mature into medullary single positive cells, before export to the periphery. Thus, thymocytes could be sorted out into two main subpopulations, the cortical immature CD2'CD3/TCR-and the medullary mature CD2+CD3/ TCR' cells."
In a previous study, we have already shown that both subpopulations were equally responding to the mitogenic activity of HTLV-1." In the present report, we indicate that either unseparated or immature thymocytes can be productively infected by HTLV-I. After infection, both subsets undergo phenotypic alterations, such as expression of activation antigens and synthesis of L-6, which was shown to be implicated in the maintenance of the in vitro proliferation. Collectively, these results provide evidence that target cells of the leukemogenic activity of HTLV-I may be recruited among human immature thymocytes.
MATERIALS AND METHODS

Antibodies and reagents.
Monoclonal antibodies (MoAbs) directed to the CDla, the CD2 epitopes T1l.l (6F10.3), and T11.2 (39C1.5). the CD3, the CD4 (IOT4a), the CD8, the CD19 and the CD54 intracellular adhesion molecule (ICAM I), and the control MoAbs of the relevant isotype (IgG1 or IgG2a) were all purchased from Immunotech (Marseille, France). Anti-CD2-PE (phycoerythrin), anti-CD3-FITC (fluorescein), anti-CD%PE, anti-CD1 la-FITC, anti-CDI&FITC, anti CD25-PE conjugated MoAbs were obtained from Dako (Copenhagen, Denmark), and anti-CD4-FITC MoAb from Biotest (Buc, France). Human anti-CD25 bloclung MoAbs (IOTI4a) and human anti-IL-6 blocking MoAbs were purchased from Immunotech and used at a final concentration of 4 pgl mL. Phytohemagglutinin (PHA), purchased from Welcome (Dratford, UK), was used at a final concentration of 10 pglmL. Mitomycin C (Sigma, St Louis, MO) was used at a final concentration of 25 & n L . Human c-IL-2 (Boehringer, Mannheim, Germany) was used at a final concentration of 25 UlmL.
Isolation of thymocyte subpopulations. Thymic tissue was obtained from normal children ranging in age from 5 months to 2 years and undergoing reparative cardiac surgery at the Neuro-Cardiologic Hospital (Pr. Champsaur. Lyon, France). A single cell suspension, prepared by teasing thymus fragments over a stainless steel mesh, was then centrifuged over Ficoll Hypaque and extensively washed. The thymocyte suspension (lo8 cellslmL) was incubated with anti-CD3, anti-CD4, anti-CD8 (2 ng/mL), anti-CDla ( 1 ng/mL), and anti-CD19 (0.2 nglmL) MoAbs for 30 minutes at 4°C according to the procedure described by Deans et al." After two extensive washings, cells were suspended in a solution of sheep antimouse IgG-coated magnetic beads (Dynabeads M450; Dynal, Oslo, Norway) at a bead cell ratio of U1. After incubation and gentle mixing for 30 minutes at 4"C, the beads were pelleted with a magnet, and the supernatant containing the negatively selected cells was collected. When necessary, one or two other cycles with magnetic beads were performed. To isolate the prothymocyte subpopulations, the thymocyte suspension (2 X 106 cells/mL) was incubated with anti-CD3, anti-CD2 MoAbs (2 nglmL) for 2 hours at 4°C. After two extensive washings, cells were incubated with magnetic beads at a beadcell ratio of 21 1, with gentle mixing for 1 hour at 4°C. Beads were removed with a magnet, and the supernatant containing the enriched prothymocyte subpopulation was collected. The pellet containing the immature thymocytes was incubated with 30 pL of detachbead (Dynal, Oslo, Norway) for l hour at room temperature with gentle mixing. Beads were pelleted with a magnet, and the immature thymocyte subpopulation was collected from the supernatant.
Proliferation assays. Thymocytes were seeded in quadruplicate at a ratio of IO4 cells per well of a 96-well flat-bottomed microdilution plate (Costar) in the complete medium in the presence or absence of blocking MoAbs at a final concentration of 4 pg/mL. Proliferation was assessed 5 days later by measuring the mitochondrial activity of the cells determined by the 3-(4,5-dimethylthiazol-2-y1)-2,5-diphenyltetrazolium bromide (MTT) assay. This assay measures the ability of viable cells to convert tetrazolium salts (Mm) within 4 hours. The optical density of each well at 570 nm was read on a multiwell scanning spectrophotometer (enzyme-linked immunosorbent assay [ELISA] reader) using a reference wavelength of 630 nm. Data are reported as means of quadruplicate cultures standard deviation (SD).
Viral infection ofthymocytes. All infections were performed by coculture using the HTLV-I-producing C91PL or MT2 cells treated by mitomycin C (25 pglmL) for 20 minutes at 37"C, in the dark. These treated cells were then washed extensively three times with Hanks' buffered solution containing 5% fetal calf serum (FCS).
Thymocytes were incubated for 72 hours with PHA (10 pg/mL) in RPMI 1640 supplemented with 10% FCS, 25 mmoVL HEPES (N-2-ethanesulfonic acid), 5 mmol/L L-glutamine, penicillin (100 U/ mL), streptomycin (50 pglmL), and human r-IL2 (25 UlmL). Thymocytes (1 X IO'lrnL) were then cocultivated with 5 X IO5 HTLV-I-producing and mitomycin-treated cells in a 24-well plate. These cultures were fed twice a week with complete RPMI medium.
Immunofluorescence andflow cytometry analysis. Expression of viral p19 and p24 antigens was determined by indirect immunofluorescence with cell fixation in methanollaceton (111) for 5 minutes at -20°C. Cells were first incubated with mouse MoAb specific for the p19 or p24 core protein (kindly provided by R.C. Gallo, National Cancer Institute, Bethesda, MD) followed by an incubation with FITC-labeled rabbit antimouse Ig (Zymed, San Francisco, CA). The presence of viral antigens was scored by fluorescence microscopy. For membrane antigen analysis, thymocytes were washed with icecold phosphate-buffered saline (PBS) containing 0.2% bovine serum albumin and 2 mmol/L sodium azide and stained with specific conjugated MoAbs for 30 minutes at 4°C. The appropriate Ig isotypes were used as negative controls. Cells were then washed with icecold PBS, fixed with a 2% paraformaldehyde solution, and analyzed by flow cytometry in a FACScan (Becton Dickinson, Mountain View, CA). Integrated fluorescence of the gated population was measured and data collected from at least 10,000 cells.
IL-6 measurement. The production of IL-6 was measured in cellfree supernatants by an ELISA lut kindly provided by Schering-Plough Corporation (Dardilly, France). The sensitivity of this ELISA assay was 150 pg/mL.
RESULTS
HTLV-I-infected human thymocytes display an immature phenotype.
Staining of unseparated thymocytes (obtained from thymus of children ranging in age from 5 months to 2 years, undergoing reparative cardiac surgery) by direct immunofluorescence and cytofluorimetry for cell surface expression of the CD3 antigen showed that the mean percentage of such thymocytes was more than 85%. Immature thymocytes (CD3-CD4-CD8-) were prepared by depletion of CD3/TCR, CD4, CD8-expressing cells using the relevant Expression of CD2, CD3, and viral p19 antigens by HTLV-l-infected thymocytes was determined by flow cytometric analysis. Cell fluorescence was analyzed on a FACScan and data from at least 10,000 analyzed events were collected.
MoAbs and sheep antimouse coated magnetic beads. On a total of four pediatric thymus samples studied, the yield of CD3ITCR-expressing cells was always found to be less than 2%. Infection by HTLV-I of unseparated thymocytes and that of immature thymocytes were performed as indicated in Materials and Methods. Briefly, either population was cultivated in the presence of PHA and IL-2 at a final concentration of 10 pg/mL and 25 U/mL, respectively. After 72 hours, they were then cultivated in the presence of mitomycin C-treated HTLV-I-producing T cells (C9 I PL or MT2) in growth medium containing IL-2. As previously described," cocultivation with HTLV-I-producing cells induced the proliferation of both types of thymocytes, whereas the HTLV-I-producing cells died and gradually disappeared from the cultures, after each weekly medium change. Two weeks after infection, an arrest in cell growth was observed, which was followed by a massive cell death. This crisis lasted 4 weeks, but spared very few cells, which started to proliferate, thus repopulating the infected culture. At that time, ie, 7 weeks after the onset of the coculture, unseparated and CD3thymocytes were tested for their status of infection with HTLV-I. Proviral DNA was detected in these cells, which also expressed viral proteins, such as gag and env proteins (data not shown). Electron microscopy observations further indicated that these thymocytes were producing viral particles, which were found to be infectious, as confirmed by their ability to infect other thymocytes (data not shown).
Four independent experiments were performed in which the phenotype of unseparated or immature thymocytes infected with HTLV-I was examined at various intervals after the onset of cocultivation. In one typical experiment (Table  I and Fig l) , unseparated thymocytes were composed of a majority of CD3' thymocytes (about 93%). Seven weeks after cocultivation, most of the infected thymocytes displayed a CD2'CD3-phenotype, as only 12% of the infected thymocytes were still expressing the CD3 antigen. Thereafter, 19 weeks after cocultivation, 96.4% of infected thymocytes did not express the CD3 antigen, at a time when the entire infected population was found to express the p19 gag antigen. Moreover, most of the infected thymocytes (about 75%) were CD4', while none of them were found to express the CD8 antigen (Fig l) . This observation suggested that the CD8' thymocytes were not proliferating. because at 7 weeks after cocultivation, 25% of the infected unseparated thymocytes were still expressing this antigen. With regard to the HTLV-I-infected immature thymocytes, their original phenotype was maintained throughout the culture period (Table  l) . Thus, I O weeks after coculture, 91% of cells were found to be CD3-. Most of them were expressing the CD4 protein (80%) (Fig l) . Finally, it should be emphasized that prolifer- ation of infected thymocytes, unseparated or immature, was consistently dependent on the presence of K-2.
Collectively, these results indicate that HTLV-I infection of unseparated thymocytes led this population to acquire an immature phenotype, as more than 95% of the infected thymocytes did not express the CD3 antigen. A plausible hypothesis is that these infected CD2+CD3-thymocytes appear as a consequence of the downmodulation of the membrane expression of the CD3 antigen. However, the possibility that they represent the progeny of the small percentage of the CD2+CD3-thymocytes present at the onset of infection could not be disregarded. Furthermore, the CD3 antigen may not be essential to achieve a productive infection, as indicated by the observations obtained with CD2+CD3-immature thymocytes.
Phenotypic characterization of HTLV-I-infected thymocytes.
To define the phenotypic alterations consecutive to HTLV-I infection, the presence of activation antigens, such as the CD25 (the ru chain of the IL2-receptor) or the CD80 (B7 antigen), which are expressed by normal activated T lymphocytes or by HTLV-I transformed T cells, was verified by cytofluorimetric analy~is.~*'~''~ As shown in Fig 2, HTLV-I-infected mature (CD2+CD3+) or immature (CD2+CD3-) thymocytes expressed both antigens at a high level. It should be noted that, in the thymus, CD25 is normally expressed by a very low percentage of cells, while the CD80 molecule, normally expressed by the thymic stromal cells, is implicated in the intrathymic T-cell development through its interaction with its ligand, the CD28 molecule expressed on the thymocyte membrane.I5 In line with these observations, we next looked for other adhesion molecules such as CD1 la, CD18 (ieukocyte function-associated antigen-1 [LFA-1 ])/CD54 (ICAM-l), which are involved in cellular interactions during thymopoiesis.16 No significant modification in the expression of CD1 l a and CD18 expression was induced by HTLV-I infection on both thymocyte subsets (not shown). Conversely, as shown in Fig 2, the CD54 molecule was found to be expressed on both mature or immature HTLV-I-infected thymocytes. Taken together, these results indicate that HTLV-I infection of thymocytes may profoundly disturb the necessary interactions occuring during T-cell development.
Modulation of the CD2 antigen expression is IL-2-dependent. Thymocytes obtained after infection of unseparated or immature thymocytes were found to be K-2-dependent for growth. Indeed, as shown in Fig 3A, removal of IL-2 from the growth medium led to a fivefold decrease in cell number, 5 weeks after IL-2 deprivation. However, when IL-2 was again added to the culture medium of those cells, they proliferated and a five to sixfold increase was observed as soon as 1 week after E -2 addition. Expression of the CD2 and CD3 antigens was monitored during the course of that experiment. Results shown in Fig 3B indicate that in cultures maintained during 3 weeks without IL-2, CD2-CD3-cells were in a majority, when compared with CD2+CD3-thymocytes, which were the most numerous at the time of E -2 removal. Of interest was the observation that these a WcCkS CD2TD3-cells were in the majority in cultures fed again with growth medium containing IL-2, as ascertained by the presence of 65% and 25% of CD2TD3-and CD2-CD3thymocytes, respectively. To determine whether these CD2TD3-cells were the progeny of either the CD2TD3or the CD2-CD3-cells present in IL-2-deprived cultures, CD2-CD3-cells were isolated from these cultures using an anti-CD2 MoAb and magnetic beads. These cells (over 95% of them were double negative) did not proliferate, but could be maintained in culture without IL-2 and were retaining the original CD2-CD3-phenotype ( Fig 4A) . However, when these cells were cultivated in presence of IL-2, about half of them present in the cultures 2 weeks later were displaying a CD2TD3-phenotype. They represented the bulk of these cultures 3 weeks after IL-2 addition ( Fig 4B) . Collectively, these results indicate that the expression of the CD2 antigen by HTLV-I-infected thymocytes is IL-2-dependent.
IL-6 is involved in the proliferation of HTLV-I-infected thymocytes. HTLV-I infection modulates the expression of cellular genes and induction of a range of cytokine genes is seen in HTLV-I-infected cell 1ines
."~19 Such induction of cytokine genes is mediated by the Tax protein, which was shown in synergy with tissue-specific cellular transcription factors, to transactivate the promoters of these genes. Indeed, significant expression of the IL-6 gene was observed in HTLV-I-infected lymphocytes,*" while neither IL-6 protein, nor mRNA were expressed by activated T cells under physiologic conditions. We also found that IL-6 could be detected in the culture supernatant of unseparated or immature thymocytes, 20 and 30 weeks after infection with HTLV-I, respectively ( Fig 5A) . Furthermore, monitoring the level of IL-6 production at regular intervals after infection with HTLV-I showed that this cytokine could be detected as early as 7 weeks after infection, at a time when more than 50% of thymocytes were expressing the p19 antigen ( Fig 5B) . As expected, no IL-6 was found in the culture supernatant of uninfected thymocytes ( Fig 5A) .
We next performed experiments to determine whether IL-6 could be involved in the proliferation of HTLV-I-infected thymocytes grown in presence of IL-2. As shown in Fig 6A, addition of an MoAb to CD25 led to a reduction in the proliferation of these cells. A much more pronounced decrease in cell proliferation was observed, when the IL-2dependent infected thymocytes were cultivated in the presence of an antibody to IL-6. No such effect ( Fig 6B) could be observed with MT2 cells, derived from virus-infected cord blood cells."
Recombinant human IL-6 has been shown to induce the expression of the a chain of the IL-2 receptor (IL2Ra) by activated murine thymocytes.2' We next performed an analysis of the expression of CD25, an epitope of the IL2Ra, on HTLV-I-infected thymocytes incubated with an MoAb to IL-6. As shown in Fig 7, a more than threefold decrease in the percentage of CD25 was observed on the membrane of thymocytes treated for 5 days with anti-lL-6 antibodies Web compared with untreated cells, whereas the MoAb to IL-6 has no effect on the CD25 expression of MT2 cells.
These results clearly indicate that the HTLV-I-induced IL-6 is involved in the proliferation of HTLV-I-infected thymocytes and might be considered as a cytokine acting in the progression of the lymphoproliferative process.
DISCUSSION
The results reported here provide evidence that HTLV-I infection of immature thymocytes may constitute an important event in the induction of the lymphoproliferative process, long before the onset of ATL. This human malignant disease had been found to be linked to HTLV-I infection early in life, at a time when the thymus is well developed." As such, the results presented here suggest that immature thymocytes, with a CD2+CD3-phenotype when infected with HTLV-I, may be considered at the origin of the monoclonal proliferation of leukemic CD4' cells, which represents the hallmark of ATL.'.' Indeed, as already demonstrated in the case of infection with animal leukemia viruses, immature cells of the hematopoietic lineage may be more prone to undergo a series of genetic events accompanying their maturation and thus inducing the occurrence of secondary events leading to the emergence of the viral leukemogenic
The same scenario can be considered in the case of HTLV-I thymocyte interactions in vivo. Conversely, even if HTLV-I infection of the more mature T lymphocytes from the peripheral blood may favor the activation and the unregu-lated proliferation of infected cells, such T cells will be unable to give rise to leukemic cells.
In vivo infection with HTLV-I correlates with the proliferation of CD4' T lymphocytes, suggesting that infection is only restricted to this cell type. However, in vitro experiments mainly performed by cocultivation methods have shown that HTLV-I is able to infect a wide variety of cell types, including not only T and B lymphocyte populations, but also endothelial and sarcoma cells, thus indicating the broad expression of the viral receptor. However, virus-induced transformation is only restricted to HTLV-I-infected T cells. In the present study, we show that infection of CD2'CD3' mature and CD2'CD3-immature thymocytes led to the proliferation of cells that express the CD4 membrane antigen.
It has been shown that double positive CD4/CDS cells were transiently observed in early phases of the in vitro HTLV-I infection of adult peripheral blood mononuclear cells." A stable cell line of double positive cells emerged from purified CD8' lymphocytes challenged with HTLV-I, but not from CD4' lymphocytes. Furthermore, double positive CD4/CD8 enriched populations consisting of fresh thymocytes or of cord blood mononuclear cells were not selected by HTLV-I infection. In the present study, doublepositive cells could not be observed after HTLV-I infection of either mature or immature thymocytes, which were depleted of CD4' and CD8' cells. Therefore, these results suggest that HTLV-I infection is inducing the maturation of selections to take place,'" the absence of expression of CD31 TCR on infected thymocytes may allow them to avoid these selection steps, these cells following thereafter an atypical mode of maturation.
Weeks after infection
We have also shown that HTLV-I-infected thymocytes are producing significant amounts of IL-6, which was found to be involved in the proliferation of these cells. These data confirm and extend previous reports of constitutive expression of this cytokine by HTLV-I transformed T-cell lines.'' IL-6, which is not synthesized by normal thymocytes and normal peripheral T cells, is a glycoprotein growth factor and differentiation regulator that is characterized by its pleiotropic activity in several cellular models and is involved in inflammation, autoimmunity, cancer, and retroviral infection. ' kines, including IL-6, confirming that Tax is upregulating IL-6 expression via the activation of nuclear transcription factors (NF-IL-6 and/or NFKB) that bind to regulatory regions within the IL-6 gene pr~moter.~' Likewise, acquired immune deficiency syndrome (AIDS) patients show high serum concentrations of IL-6 that has been shown to be associated with the proliferation of Kaposi sarcoma cells.30 In the thymus, IL-6 is normally produced by stromal cells, and more particularly by epithelial cells, suggesting that IL-6 participates in T-cell de~elopment.~' Experiments performed with an MoAb to IL-6 clearly demonstrate that the induced expression of IL-6 by HTLV-I-infected thymocytes is directly implicated in the proliferation of these cells and in the induction of the a chain of the E -2 receptor (IL-2Ra). As such, IL-6 could synergize with the Tax protein in inducing the IL-2 receptor, because a study on the temporal regulation of viral and cellular gene expression during HTLV-Imediated lymphocyte immortalization indicates that the high level of expression of IL-2Ra mRNA was independent of the level of tax transcript^.^^ However, that may be the abnormal synthesis of L-6 by HTLV-I-infected thymocytes and the detection on their membrane of activation and adhesion antigens not normally found on uninfected thymocytes suggest that thymus infection by this retrovirus is pertubating the course of T-cell development.
Infection early in life is occuring via breastfeeding of neonates by HTLV-I-seropositive mothers.6 Indeed, numerous lymphocytes carrying the HTLV-I provirus were found in the milk of these mothers and should be able to enter the body through the pharynx or the mouth epithelium of the neonate^.^^.^^ Alternatively, gut epithelial cells may represent the first target cells of viral i n f e~t i o n ,~~ which will then be disseminated towards other tissues in the organism. Indeed, in mice that have been infected with an exogenous mouse mammary tumor virus via maternal milk intake, proviral transcripts were only found in the gut in the first week of life, whereafter they could be detected in the thymus, spleen, and lymph nodes.37 All considered, in vivo thymus infection with HTLV-I (which has not yet been reported) could be a rare event, correlating with the low percentage of HTLV-Iinfected individuals developing ATL when reaching the adult age. The setting of an experimental model in rabbits or rats might help to trace HTLV-I after milk ingestion by newborn animals.
The present study is the first to provide evidence that target cells of the leukemogenic activity of HTLV-I may be recruited among human immature thymocytes, before the membrane expression of the CD3/TCR complex. More precisely, the immediate effect of HTLV-I infection of these cells at an early stage of T-cell development will be to alter their proliferation and their maturation, a late consequence being the emergence of leukemic cells favored by the successive genetic developmental switches characteristic of thymopoiesis. As a good understanding of the pathways of intrathymic T-cell development has now been a~h i e v e d ,~' .~~ the response to HTLV-I infection of immature cells at different stages of differentiation should be investigated to provide further support of the link between infection of T-cell precursors and ATL.
